7 results
IDSA Recommendations for Treating Mucosal Candidiasis in HIV-AIDS
Oropharyngeal Candidiasis: Initial Episodes (Duration of Therapy: 7–14 days)
Preferred
chew, or crush tablet ... Refer to product label ... mucosal #IDSA #Prevention ... #Treatment #management ... opportunistic #infections
Guillain-Barre Syndrome - Summary

Acute AIDP that presents with rapidly progressive flaccid weakness

Epidemiology:
 • 1-2 cases/100,000 per
response preceding infection ... Life threatening labile ... Treatment: • Plasmapheresis ... #diagnosis #management ... #treatment #neurology
Diuretics and Agents Regulating Renal Excretion

Carbonic Anhydrase Inhibitors (Acetazolamide, Dichlorphenamide)
 • Glaucoma
 • Epilepsy
 • Altitude
irrigation • Management ... nocturnal enuresis • Prevention ... Tolvaptan) • Treatment ... #Pharmacology #Medications ... #Table
IDSA Recommendations for Preventing and Treating Histoplasma Capsulatum Infections in HIV-AIDS
Indications for Initiating Primary Prophylaxis:
 •
Recommendations for Preventing ... Histoplasma Capsulatum Infections ... in HIV-AIDS Indications ... with ARV (see Table ... #Treatment #management
Probiotics Guidelines
Adults with C difficile infection
 • Recommendation: Only in the context of a clinical trial
with C difficile infection ... on antibiotic treatment ... irritable bowel syndrome ... Probiotics #Guidelines #gastroenterology ... #management #evidence
IDSA Recommendations for Preventing and Treating Disseminated Mycobacterium Avium Complex in HIV-AIDS
Preventing 1st Episode of Disseminated
Recommendations for Preventing ... Prophylaxis): Indications ... please refer to Table ... #Treatment #management ... opportunistic #infections
IDSA Recommendations for Treating Mycobacterium Tuberculosis Infection and Disease in HIV-AIDS
Treating LTBI (to prevent TB disease)
Indications:
prevent TB disease) Indications ... a person with infectious ... Please refer to the table ... Tuberculosis #TB #IDSA #Prevention ... #Treatment #management